The Company is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, feed and medical sterilization industries.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
BalChem rules.
Consistent management; Great acquisition integration; nothing stopping them from continuing their growth; beautifully cautious and successful expansion of their product lines.
Solid sales growth. (Net) debt-free.
Excellent bottom line growth- 475% over last 9 years...21.5%/year.
I like this stock as much as I like Catherine Zeta Jones, and BalChem's got sexier figures. Listing on the Nasdaq should give it more exposure.